Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
daclatasvir (daklinza) (1 trial)
sofosbuvir (sovaldi) (1 trial)
Hepatitis (Phase 3)
Hepatitis A (Phase 3)
Hepatitis C (Phase 3)
Trials (1 total)
Trial APIs (2 total)